Business Development

Client Type

Business Development

Corporate M&A
Required an external assessment of a potential M&A target in the rare disease space

Needs

The head of business development at a mid-size pharma company required an external assessment of a potential M&A (merger and acquisition) target in the rare disease space to help inform decision-making and potential deal terms.

Why ClearView

ClearView’s experience in the rare disease space, ability to provide an unbiased perspective regarding future commercial opportunity associated with the target company’s portfolio, and willingness to act as “devil’s advocate” around key strategic issues were highly valued by the client.